The Use of Statins and Risk of Community-Acquired Pneumonia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Infectious Disease Reports

• Publication date

  2017-06-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11908-017-0581-xPMID 28639080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014

  2016cited by this paper
• Statin use associated with a reduced risk of pneumonia requiring hospitalization in patients with myocardial infarction: a nested case-control study

  2016cited by this paper
• Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia.

  2016cited by this paper
• Community-acquired pneumonia: still a major burden of disease

  2016cited by this paper
• Community-acquired pneumonia requiring hospitalization among U.S. children.

  2015cited by this paper
• Global , regional , and national age – sex specifi c all-cause and cause-specifi c mortality for 240 causes of death , 1990 – 2013 : a systematic analysis for the Global Burden of Disease Study 2013

  2015cited by this paper
• Statin-conferred enhanced cellular resistance against bacterial pore-forming toxins in airway epithelial cells.

  2015cited by this paper
• The Burden and Etiology of Community-Onset Pneumonia in the Aging Japanese Population: A Multicenter Prospective Study

  2015cited by this paper
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2015cited by this paper
• Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study

  2015cited by this paper
• Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies.

  2015cited by this paper
• Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the Global Trigger Tool method.

  2015cited by this paper
• Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.

  2015cited by this paper
• The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

  2015cited by this paper
• Non-antibiotic therapies for CAP

  2014cited by this paper
• The antithrombotic effects of statins.

  2014cited by this paper
• The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

  2013cited by this paper
• High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins.

  2013cited by this paper
• The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-Analysis

  2013cited by this paper
• Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.

  2013cited by this paper
• Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease

  2013cited by this paper
• Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia

  2012cited by this paper
• The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study

  2012cited by this paper
• Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis.

  2012cited by this paper
• Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis.

  2012cited by this paper
• The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial

  2012cited by this paper
• Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption

  2012cited by this paper
• Risk of pneumonia in patients taking statins: population-based nested case-control study.

  2011cited by this paper
• Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies

  2011cited by this paper
• Simvastatin is protective during Staphylococcus aureus pneumonia.

  2011cited by this paper
• Statins inhibit Rho kinase activity in patients with atherosclerosis.

  2009cited by this paper
• Statin use and risk of community acquired pneumonia in older people: population based case-control study

  2009cited by this paper
• Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study

  2009cited by this paper
• Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.

  2009cited by this paper
• Risk of community‐acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population‐based case–control study

  2009cited by this paper
• Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.

  2009cited by this paper
• Harmful molecular mechanisms in sepsis

  2008cited by this paper
• Statins and the Risk of Pneumonia: A Population‐Based, Nested Case‐Control Study

  2007cited by this paper
• Modulation of ADP-Induced Platelet Activation by Aspirin and Pravastatin: Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Nitric Oxide, Oxidative Stress, and Inside-Out Integrin Signaling

  2007cited by this paper
• Statin treatment and reduced risk of pneumonia in patients with diabetes

  2006cited by this paper
• Effect of Simvastatin, an Established Lipid-Lowering Drug, on Pulmonary Chlamydia pneumoniae Infection in Mice

  2005cited by this paper
• Lipid rafts are required in Gαi signaling downstream of the P2Y12 receptor during ADP‐mediated platelet activation

  2005cited by this paper
• Community-acquired pneumonia.

  1995cited by this paper

• Impact of Long-Term Statin Therapy on Incidence and Severity of Community-Acquired Pneumonia: A Real-World Data Analysis

  2025cites this paper
• The Association between Dyslipidemia and Pulmonary Diseases

  2024cites this paper
• Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association

  2023cites this paper
• Research Advances in Pneumococcal Community-Acquired Pneumonia-Related Cardiovascular Complications

  2022cites this paper
• COVID-19 and diabetes: will novel drugs for diabetes help in COVID-19?

  2022cites this paper
• Cardiovascular Complications in COVID-19 Pandemic and Its Management

  2021cites this paper
• Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics

  2020cites this paper
• Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

  2020cites this paper
• Role of statins in controlling cough and improving lung function and exercise capacity in bronchiectasis patients.

  2020cites this paper
• Effects of statins on clinical outcomes in hospitalized patients with community-acquired pneumonia

  2020cites this paper
• Personalizing the Management of Pneumonia.

  2018cites this paper
• Particulate Matter and Respiratory Diseases: How Far Have We Gone?

  2018cites this paper
• Association between neurodegenerative diseases and pneumonia: a retrospective population-based study

  2018cites this paper